Grupa Azoty (ATT) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
27 Oct, 2026Executive summary
9M 2025 revenue was PLN 10.035bn and EBITDA PLN 312.1m, while net loss reached PLN 1.027bn; results faced weak markets, elevated gas costs and Polyolefins disruption.
Q3 EBITDA was PLN 390.9m, including a PLN 315.9m one-off EPC settlement; adjusted EBITDA was PLN 75m.
Financing agreements were extended to 28 November 2025; longer-term stabilization, restructuring and continued operations at an unchanged scale remain uncertain.
Financial highlights
9M revenue rose to PLN 10.035bn from PLN 9.828bn; operating loss was PLN 534.2m, pretax loss PLN 1.018bn and net loss PLN 1.027bn.
9M EBITDA was PLN 312.1m versus a PLN 299m loss; excluding Polyolefins, EBITDA was PLN 346m versus a PLN 186m loss.
Q3 revenue fell 6.2% YoY to PLN 2.894bn; gross profit was PLN 185.5m, EBIT PLN 105.4m and net loss PLN 149.8m.
9M operating cash flow was PLN 5.435bn, investing outflow PLN 366.0m and financing outflow PLN 4.935bn; cash ended at PLN 826.1m, including restricted balances.
9M financial costs were PLN 812.8m, including PLN 694.8m interest expense; financial income included PLN 276.7m in FX gains.
Outlook and guidance
2030 targets include annual revenue of PLN 17–18bn, EBITDA of PLN 1.9–2.0bn, EBITDA margin above 10%, net debt/EBITDA below 2.5x and CAPEX of PLN 3–4bn for 2025–2030.
2030 targets include fertilizer revenue of PLN 11–12bn at 9–10% EBITDA margin, logistics revenue above PLN 0.6bn at a margin above 30%, and defense chemicals revenue of PLN 600–800m at 40–50% margin.
AZOTY BUSINESS began in March 2025 and runs through 2027; reported benefits included PLN 144m in payroll-cost savings and PLN 39m from non-operating asset sales.
Market outlook remains subdued for polymers, OXO products and plasticizers; fertilizer demand may pick up ahead of 2026 applications, while CBAM may raise costs and prompt pre-buying.
Latest events from Grupa Azoty
- Sales grew, but losses, market headwinds and financing uncertainty persisted.ATT
Q1 2025 - Agro-led EBITDA recovery paired with GAP restructuring targets a sharp debt reduction.ATT
Q4 2025 - EBITDA rebounded to PLN 316.5m, but funding risks and Polyolefins’ conditional sale remain.ATT
Q1 2026 - Q2 EBITDA rebounded, but financing and restructuring risks persist.ATT
Q2 2026 - Q2 EBITDA rebounded to PLN 294m as Chemicals and Agro strengthened.ATT
Q2 2026 - EBITDA surged to PLN 316.5 million as profitability improved and restructuring advanced.ATT
Q1 2026 - EBITDA rebounded on a one-off gain, with revenue up and major restructuring underway.ATT
Q3 2025 - Revenue up 12.4% YoY; Agro leads growth, but net loss persists amid restructuring.ATT
Q1 2025 - EBITDA improved and net loss narrowed, supported by cost cuts and CapEx reduction.ATT
Q4 2024